{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:06:26Z","timestamp":1760781986254,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.canlet.2023.216153","type":"journal-article","created":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T14:53:53Z","timestamp":1680706433000},"page":"216153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The diverse pancreatic tumor cell-intrinsic response to IFN\u03b3 is determined by epigenetic heterogeneity"],"prefix":"10.1016","volume":"562","author":[{"given":"Yueyue","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuqing","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dapeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feier","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4210-0136","authenticated-orcid":false,"given":"Ningning","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216153_bib1","first-page":"7","article-title":"Cancer statistics","volume":"72","author":"Siegel","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216153_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canlet.2020.04.018","article-title":"Hypoxia and pancreatic ductal adenocarcinoma","volume":"484","author":"Yamasaki","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib3","first-page":"375","article-title":"Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma","volume":"70","author":"Grossberg","year":"2020","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.canlet.2023.216153_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/JP9.0000000000000086","article-title":"Real-world study of surgical treatment of pancreatic cancer in China: annual report of China Pancreas Data Center (2016-2020)","volume":"5","author":"Wu","year":"2022","journal-title":"Journal of Pancreatology"},{"key":"10.1016\/j.canlet.2023.216153_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2023.216153_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2016.12.035","article-title":"Pancreatic cancer: stroma and its current and emerging targeted therapies","volume":"391","author":"Kota","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2021.08.029","article-title":"Tumor microenvironment and metabolic remodeling in gemcitabine-based chemoresistance of pancreatic cancer","volume":"521","author":"Gu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920923424","article-title":"Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis","volume":"12","author":"Chae","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.canlet.2023.216153_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215864","article-title":"Genome-wide CRISPR screen identifies MTA3 as an inducer of gemcitabine resistance in pancreatic ductal adenocarcinoma","volume":"548","author":"Wu","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy, Nature reviews","volume":"18","author":"Riley","year":"2019","journal-title":"Drug Discov."},{"key":"10.1016\/j.canlet.2023.216153_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and opportunities for pancreatic cancer immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.01.031","article-title":"Trials and tribulations of pancreatic cancer immunotherapy","volume":"504","author":"Principe","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2020.06.011","article-title":"Neoantigen-based immunotherapy in pancreatic ductal adenocarcinoma (PDAC)","volume":"490","author":"Chen","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib14","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1158\/2159-8290.CD-20-1661","article-title":"IFN\u03b3 is critical for CAR T cell-mediated myeloid activation and induction of endogenous immunity","volume":"11","author":"Alizadeh","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2023.216153_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.canlet.2017.09.002","article-title":"Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines","volume":"410","author":"Cekay","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153167","article-title":"Histone methyltransferase WHSC1 loss dampens MHC-I antigen presentation pathway to impair IFN-\u03b3-stimulated antitumor immunity","volume":"132","author":"Ren","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216153_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2021.03.002","article-title":"Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC)","volume":"506","author":"Yan","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib18","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1245\/s10434-019-07338-3","article-title":"Tumor heterogeneity correlates with less immune response and worse survival in breast cancer patients","volume":"26","author":"McDonald","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2023.216153_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216153_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.canlet.2008.03.056","article-title":"Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer","volume":"268","author":"Loos","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib21","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1158\/0008-5472.CAN-19-2689","article-title":"Perineural invasion reprograms the immune microenvironment through cholinergic signaling in pancreatic ductal adenocarcinoma","volume":"80","author":"Yang","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216153_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/IL-15Ralpha axis promotes anti-tumor immunity in pancreatic cancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/gutjnl-2019-320441","article-title":"CDK1\/2\/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer","volume":"70","author":"Huang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2023.216153_bib24","first-page":"49","article-title":"Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer","volume":"2","author":"Li","year":"2021","journal-title":"Nat Can"},{"key":"10.1016\/j.canlet.2023.216153_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2023.216153_bib26","article-title":"Tumor cell-intrinsic SETD2 deficiency reprograms neutrophils to foster immune escape in pancreatic tumorigenesis","author":"Niu","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.canlet.2023.216153_bib27","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","article-title":"Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response","volume":"24","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2023.216153_bib28","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1158\/0008-5472.CAN-20-3186","article-title":"Inhibition of the FACT complex targets aberrant hedgehog signaling and overcomes resistance to smoothened antagonists","volume":"81","author":"Mo","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2023.216153_bib29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.canlet.2023.216153_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.immuni.2009.09.002","article-title":"Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases","volume":"31","author":"Hu","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216153_bib31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.canlet.2023.216153_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-21-3226","article-title":"IFN\u03b3 signaling in natural and therapy-induced antitumor responses","volume":"28","author":"Mart\u00ednez-Sabadell","year":"2022","journal-title":"Clin. Cancer Res. : Off. J. American Assoc. Can. Res."},{"key":"10.1016\/j.canlet.2023.216153_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2023.216153_bib34","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.canlet.2012.10.005","article-title":"Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis","volume":"328","author":"McCleary-Wheeler","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216153_bib35","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","article-title":"Interferon target-gene expression and epigenomic signatures in health and disease","volume":"20","author":"Barrat","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2023.216153_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-017-0600-4","article-title":"Intra-tumor heterogeneity from a cancer stem cell perspective","volume":"16","author":"Prasetyanti","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2023.216153_bib37","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jamaoncol.2015.3638","article-title":"Quantitative assessment of the heterogeneity of PD-L1 expression in non-small-cell lung cancer","volume":"2","author":"McLaughlin","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2023.216153_bib38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/s41596-018-0113-7","article-title":"Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute","volume":"14","author":"Wang","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.canlet.2023.216153_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s40425-019-0784-9","article-title":"EZH2 negatively regulates PD-L1 expression in hepatocellular carcinoma","volume":"7","author":"Xiao","year":"2019","journal-title":"J. Immunother. Can."},{"key":"10.1016\/j.canlet.2023.216153_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature11262","article-title":"A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response","volume":"488","author":"Kruidenier","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216153_bib41","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ccell.2022.05.006","article-title":"Exercise-induced engagement of the IL-15\/IL-15R\u03b1 axis promotes anti-tumor immunity in pancreatic cancer","volume":"40","author":"Kurz","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomarker Res."},{"key":"10.1016\/j.canlet.2023.216153_bib43","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1016\/j.celrep.2016.08.051","article-title":"IFN-\u0393 induces histone 3 lysine 27 trimethylation in a small subset of promoters to stably silence gene expression in human macrophages","volume":"16","author":"Qiao","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2023.216153_bib44","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13148-022-01316-5","article-title":"Distinct modulation of IFN\u03b3-induced transcription by BET bromodomain and catalytic P300\/CBP inhibition in breast cancer","volume":"14","author":"Hogg","year":"2022","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.canlet.2023.216153_bib45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216153_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.immuni.2013.08.009","article-title":"Synergistic activation of inflammatory cytokine genes by interferon-\u03b3-induced chromatin remodeling and toll-like receptor signaling","volume":"39","author":"Qiao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2023.216153_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41576-020-00300-0","article-title":"The epigenetic basis of cellular heterogeneity","volume":"22","author":"Carter","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2023.216153_bib48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning cold into hot: firing up the tumor microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Can."},{"key":"10.1016\/j.canlet.2023.216153_bib49","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis","volume":"184","author":"Mathewson","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib50","first-page":"1050","article-title":"Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells","volume":"8","author":"Marrufo","year":"2018","journal-title":"American J. Can. Res."},{"key":"10.1016\/j.canlet.2023.216153_bib51","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the Ido1\/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2023.216153_bib52","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.molcel.2021.03.019","article-title":"Immune-regulated Ido1-dependent tryptophan metabolism is source of one-carbon units for pancreatic cancer and stellate cells","volume":"81","author":"Newman","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib53","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.cell.2021.09.020","article-title":"Hallmarks of response, resistance, and toxicity to immune checkpoint blockade","volume":"184","author":"Morad","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2023.216153_bib54","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1172\/JCI91190","article-title":"IFN-\u03b3-related mRNA profile predicts clinical response to PD-1 blockade","volume":"127","author":"Ayers","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216153_bib55","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI127726","article-title":"The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy","volume":"129","author":"Wei","year":"2019","journal-title":"J. Clin. Invest."},{"volume":"vol. 2","year":"2019","author":"Bullock","key":"10.1016\/j.canlet.2023.216153_bib56"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523001040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523001040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:08:35Z","timestamp":1759594115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523001040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":56,"alternative-id":["S0304383523001040"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216153","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverse pancreatic tumor cell-intrinsic response to IFN\u03b3 is determined by epigenetic heterogeneity","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216153"}}